International Journal of Pharmaceutical Investigation logo
Submit
International Journal of Pharmaceutical InvestigationACADEMIC PUBLISHING
Review

A Detailed Insight of Monkey Pox Virus Infection in Adolescent

1★, 1, 1, 1, 1, 1★ Corresponding author

  1. 1Department of Pharmacy, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, INDIA.

CORRESPONDENCE

Ankita Wal

Department of Pharmacy, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, INDIA.

walankita@gmail.com

Received: 06-10-2022; Revised: 24-10-2022; Accepted: 30-11-2022.

Volume 13, Issue 2 · pp. 215-223 · 2023 · DOI: 10.5530/ijpi.13.2.029

ABSTRACT

Background: Smallpox-like symptoms are seen in the viral zoonotic illness known as monkeypox. In the current outbreaks being reported, the World Health Organization (WHO) claims that this is the first instance of chains of transmission being documented in Europe without known epidemiological connections to West or Central Africa. On August 7, 2022, the WHO reported a total of 27,815 confirmed cases in over 89 countries, with the majority of those affected experiencing monkeypox for the first time. The objective of this article is to provide a succinct overview of the monkey pox, its transmission mechanisms, and available preventative methods in adolescents.Materials and Methods: Several databases, including WHO guidelines, PubMed, Bentham Science, and Elsevier, were used to compile the data for the article following a thorough analysis of the various research findings connected to monkey pox infection, pathogenesis, and available treatments.Results: Monkeypox is a zoonotic orthopoxvirus that causes disease in humans similar to smallpox. Complications are more likely in children and the immunocompromised. Treatment is largely symptomatic. The first-line treatment for monkeypox, including in kids and teenagers, is tecovirimat.Conclusion: We came to the conclusion from this review that adolescents and adults both transmit the monkey pox virus. The most common sign of monkeypox in kids and teens is a rash that starts out as maculopapular lesions and turns into vesicles, pustules, and then scabs, just like diseases in adults. Children and adolescents who have been exposed to individuals with suspected or confirmed monkeypox may benefit from Post-Exposure Prophylaxis (PEP) with vaccination, immune globulin, or antiviral medicine.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Wal, A., Vishnoi, G., Gupta, D., Srivastava, P., Wal, P., & Rai, A. K. (2023). A Detailed Insight of Monkey Pox Virus Infection in Adolescent. International Journal of Pharmaceutical Investigation, 13(2), 215-223. https://doi.org/10.5530/ijpi.13.2.029

    Copyright and licence

    © 2023 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0